- What does the medical/health condition of those 5 or more years from diagnosis of IBC reveal? To what degree can current health conditions be attributed to prior treatment for IBC?
- What is the benefit of including anti-angiogenesis treatment with induction chemotherapy? see VEGF-C, VEGF-D and VEGFR-3 in Tumor Angiogenesis, Lymphangiogenesis and Metastasis and Expression of vascular endothelial growth factor (VEGF) family members in breast cancer.
- When is there going to be a clinical trial for IBC patients using a Farnesyltransferase Inhibitor? see Prenylation of Proteins, Farnesyltransferase inhibitors: mechanism and applications, and RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.
- What does the analysis of results of 50 to 300 autopsies of IBC patients reveal?
Updating...
